Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kaminsky R., Moriarty T. M., Bodine J., Wolf D. E., Davidson M. Effect of famotidine on deficit symptoms of schizophrenia. Lancet. 1990 Jun 2;335(8701):1351–1352. doi: 10.1016/0140-6736(90)91237-5. [DOI] [PubMed] [Google Scholar]
- Oyewumi L. K., Vollick D., Merskey H., Plumb C. Famotidine as an adjunct treatment of resistant schizophrenia. J Psychiatry Neurosci. 1994 Mar;19(2):145–150. [PMC free article] [PubMed] [Google Scholar]
- Rao M. L. Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity. Psychopharmacology (Berl) 1986;90(4):548–553. doi: 10.1007/BF00174077. [DOI] [PubMed] [Google Scholar]
- Spitzer R. L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978 Jun;35(6):773–782. doi: 10.1001/archpsyc.1978.01770300115013. [DOI] [PubMed] [Google Scholar]
- Stedman T. J., Whiteford H. A., Eyles D., Welham J. L., Pond S. M. Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. J Clin Psychopharmacol. 1991 Feb;11(1):43–47. [PubMed] [Google Scholar]